scispace - formally typeset
C

Changquan Calvin Sun

Researcher at University of Minnesota

Publications -  248
Citations -  10301

Changquan Calvin Sun is an academic researcher from University of Minnesota. The author has contributed to research in topics: Tableting & Cocrystal. The author has an hindex of 45, co-authored 223 publications receiving 8070 citations. Previous affiliations of Changquan Calvin Sun include Pharmacia & Pfizer.

Papers
More filters
Journal ArticleDOI

Formulation strategies for mitigating dissolution reduction of p-aminobenzoic acid by sodium lauryl sulfate through diffusion layer modulation.

TL;DR: In this paper, the authors examined two formulation strategies for mitigating the negative effect of SLS on the dissolution of p-aminobenzoic acid (PABA) by reducing the Q value of its LS salt in the diffusion layer: 1) introducing alkalizing excipient, Na3PO4, to reduce the concentration of PABAH+ by elevating the microenvironment pH, and 2) introducing NaCl to reduce LS- monomer concentration by depressing the critical micelle concentration (CMC).
Book ChapterDOI

Structures and properties of granules prepared by high shear wet granulation

TL;DR: In this paper, the authors focus on the evolution of granule structures and its connection to properties of granules prepared by high shear wet granulation (HSWG) and discuss the importance of integrated materials science and engineering in solving problems in pharmaceutical product development and manufacturing.
Journal ArticleDOI

Effects of shear cell size on flowability of powders measured using a ring shear tester

TL;DR: In this article, the authors systematically evaluated the flowability of powders under three preshear normal stresses using a ring shear tester, and the results showed that flowability was positively associated with shear cell size.
Journal ArticleDOI

A microcrystalline cellulose based drug-composite formulation strategy for developing low dose drug tablets.

TL;DR: Compared to traditional ways to address content uniformity problems, this formulation strategy is much more robust and simpler, making it a potential platform technology for manufacturing tablets of potent APIs.